Literature DB >> 35258669

Avermectin B1a production in Streptomyces avermitilis is enhanced by engineering aveC and precursor supply genes.

Yi Hao1, Yanting You1, Zhi Chen1, Jilun Li1, Gang Liu2, Ying Wen3.   

Abstract

Avermectins (AVEs) are economically potent anthelmintic agents produced by Streptomyces avermitilis. Among eight AVE components, B1a exhibits the highest insecticidal activity. The purpose of this study was to enhance B1a production, particularly in the high-yielding industrial strain A229, by a combination strategy involving the following steps. (i) aveC gene was engineered to increase B1a:B2a ratio. Three aveC variants (aveC2m, aveC5m, and aveC8m, respectively encoding two, five, and eight amino acid mutations) were synthesized by fusion PCR. B1a:B2a ratio in A229 derivative having kasOp*-controlled aveC8m reached 1.33 (B1a and B2a titers were 8120 and 6124 μg/mL). Corresponding values in A229 were 0.99 and 6447 and 6480 μg/mL. (ii) β-oxidation pathway genes fadD and fadAB were overexpressed in wild-type (WT) strain and A229 to increase supply of acyl-CoA precursors for AVE production. The resulting strains all showed increased B1a titer. Co-overexpression of pkn5p-driven fadD and fadAB in A229 led to B1a titer of 8537 μg/mL. (iii) Genes bicA and ecaA involved in cyanobacterial CO2-concentrating mechanism (CCM) were introduced into WT and A229 to enhance carboxylation velocity of acetyl-CoA and propionyl-CoA carboxylases, leading to increased supply of malonyl- and methylmalonyl-CoA precursors and increased B1a titer. Co-expression of bicA and ecaA in A229 led to B1a titer of 8083 μg/mL. (iv) aveC8m, fadD-fadAB, and bicA-ecaA were co-overexpressed in A229, resulting in maximal B1a titer (9613 μg/mL; 49.1% increase relative to A229). Our findings demonstrate that the combination strategy we provided here is an efficient approach for improving B1a production in industrial strains.Key points• aveC mutation increased avermectin B1a:B2a ratio and B1a titer.• Higher levels of acyl-CoA precursors contributed to enhanced B1a production.• B1a titer in an industrial strain was increased by 49.1% via a combination strategy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Avermectin B1a; Avermectins; Precursor supply; Streptomyces avermitilis; aveC

Mesh:

Substances:

Year:  2022        PMID: 35258669     DOI: 10.1007/s00253-022-11854-w

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  38 in total

1.  Selamectin: a novel broad-spectrum endectocide for dogs and cats.

Authors:  B F Bishop; C I Bruce; N A Evans; A C Goudie; K A Gration; S P Gibson; M S Pacey; D A Perry; N D Walshe; M J Witty
Journal:  Vet Parasitol       Date:  2000-08-23       Impact factor: 2.738

Review 2.  Genetic approaches for controlling ratios of related polyketide products in fermentation processes.

Authors:  A Cropp; S Chen; H Liu; W Zhang; K A Reynolds
Journal:  J Ind Microbiol Biotechnol       Date:  2001-12       Impact factor: 3.346

3.  Transcriptional regulation of the macs1-fadD1 operon encoding two acyl-CoA synthases involved in the physiological differentiation of Streptomyces coelicolor.

Authors:  Ana Arabolaza; Claudia Banchio; Hugo Gramajo
Journal:  Microbiology       Date:  2006-05       Impact factor: 2.777

Review 4.  Biosynthesis of polyketide synthase extender units.

Authors:  Yolande A Chan; Angela M Podevels; Brian M Kevany; Michael G Thomas
Journal:  Nat Prod Rep       Date:  2009-01       Impact factor: 13.423

5.  Avermectins and flea control: structure-activity relationships and the selection of selamectin for development as an endectocide for companion animals.

Authors:  B J Banks; B F Bishop; N A Evans; S P Gibson; A C Goudie; K A Gration; M S Pacey; D A Perry; M J Witty
Journal:  Bioorg Med Chem       Date:  2000-08       Impact factor: 3.641

6.  Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp.

Authors:  M Bierman; R Logan; K O'Brien; E T Seno; R N Rao; B E Schoner
Journal:  Gene       Date:  1992-07-01       Impact factor: 3.688

7.  A stationary-phase acyl-coenzyme A synthetase of Streptomyces coelicolor A3(2) is necessary for the normal onset of antibiotic production.

Authors:  C Banchio; H Gramajo
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

8.  Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component.

Authors:  J R Egerton; D A Ostlind; L S Blair; C H Eary; D Suhayda; S Cifelli; R F Riek; W C Campbell
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

9.  Ivermectin: a potent new antiparasitic agent.

Authors:  W C Campbell; M H Fisher; E O Stapley; G Albers-Schönberg; T A Jacob
Journal:  Science       Date:  1983-08-26       Impact factor: 47.728

10.  Efficacy of an in-feed preparation of ivermectin against helminths in the European wild boar.

Authors:  Isabel G Fernandez-de-Mera; Joaquín Vicente; Christian Gortazar; Ursula Höfle; Yolanda Fierro
Journal:  Parasitol Res       Date:  2003-11-25       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.